| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $228.3M | +102.7% |
| Cost of Revenue | $79.7M | +250.1% |
| Gross Profit | $148.6M | +65.3% |
| R&D Expense | $102.5M | +101.0% |
| SG&A Expense | $48.1M | +103.3% |
| Operating Income | -$94.4M | -192.6% |
| Pre-tax Income | -$91.3M | -171.1% |
| Income Tax | $312K | +345.7% |
| Net Income | -$91.6M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $75.4M | -67.3% |
| Accounts Receivable | $33.1M | +181.4% |
| Inventory | $10.8M | +438.9% |
| Current Assets | $142.7M | -44.4% |
| Total Assets | $339.6M | +12.3% |
| Current Liabilities | $87.6M | +111.5% |
| Long-term Debt | $7.6M | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$57.1M | -369.5% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | -$111.6M | -1480.3% |
| Financing Cash Flow | $27.7M | -85.7% |
| Free Cash Flow | -$57.1M | -366.4% |
| -173.1% |
| EPS (Basic) | -$1.47 | -126.2% |
| EPS (Diluted) | -$1.50 | -130.8% |
| Total Liabilities |
| $95.1M |
| +81.7% |
| Stockholders' Equity | $244.5M | -2.2% |